Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...

Grifols ends acquisition talks with Brookfield over valuation concerns, highlights strong revenue growth and financial ...

Grifols (NASDAQ:GRFS) has commenced discussions with banks to refinance its bonds due in 2025, Bloomberg News reported, a day ...

La farmacéutica española Grifols SA está en conversaciones con bancos para refinanciar bonos que vencen el próximo año y ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

Fortress is offering 310p per share, valuing the total equity of the company at around £338 million ($428 million; €406 ...

In Europe, the Stoxx Europe 600 gained 0.4% in morning trading. Direct Line Insurance rose 36.4% and BE Semicon Industries added 5.4%. On the other hand, Grifols dropped 3%, and LEG Immobilien fell ...

The Canadian fund Brookfield has decided to withdraw its interest in a public exclusion offer to acquire Grifols due to ...

The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...

Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following ...

Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over ...

In a notice to the Spanish National Securities Market Commission, Grifols (GRFS) stated: “Grifols announces that its Board of Directors held an ...